Literature DB >> 18076102

Prenatal and postnatal presentation of severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) due to the FGFR3 Lys650Met mutation.

Andreas Zankl1, George Elakis, Rachel D Susman, Garry Inglis, Glenn Gardener, Michael F Buckley, Tony Roscioli.   

Abstract

We present prenatal and postnatal features of a patient with severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN). Mutation analysis confirmed the clinical diagnosis by detecting the FGFR3 Lys650Met mutation. This case, one of only six with molecular analysis reported in the literature, confirms the severe morbidity and adds to the reports with early mortality associated with SADDAN. Clinical-radiological characteristics of all reported cases of SADDAN are reviewed and discussed. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18076102     DOI: 10.1002/ajmg.a.32085

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  FGFR3-related condition: a skeletal dysplasia with similarities to thanatophoric dysplasia and SADDAN due to Lys650Met.

Authors:  Shannon G Farmakis; Marwan Shinawi; Michelle Miller-Thomas; Alireza Radmanesh; Thomas E Herman
Journal:  Skeletal Radiol       Date:  2014-08-15       Impact factor: 2.199

2.  Clinical management and emerging therapies of FGFR3-related skeletal dysplasia in childhood.

Authors:  Hwa Young Kim; Jung Min Ko
Journal:  Ann Pediatr Endocrinol Metab       Date:  2022-06-30

3.  Novel phenotype of achondroplasia due to biallelic FGFR3 pathogenic variants.

Authors:  Irene J Chang; Angela Sun; Maryse L Bouchard; Shawn E Kamps; Susan Hale; Stephen Done; Michael J Goldberg; Ian A Glass
Journal:  Am J Med Genet A       Date:  2018-07       Impact factor: 2.802

4.  Characterization of pathogenic germline mutations in human protein kinases.

Authors:  Jose M G Izarzugaza; Lisa E M Hopcroft; Anja Baresic; Christine A Orengo; Andrew C R Martin; Alfonso Valencia
Journal:  BMC Bioinformatics       Date:  2011-07-05       Impact factor: 3.169

5.  FGFR3 mutation frequency in 324 cases from the International Skeletal Dysplasia Registry.

Authors:  Yuan Xue; Angela Sun; P Betty Mekikian; Jorge Martin; David L Rimoin; Ralph S Lachman; William R Wilcox
Journal:  Mol Genet Genomic Med       Date:  2014-08-05       Impact factor: 2.183

6.  Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors.

Authors:  Anne Goriely; Ruth M S Hansen; Indira B Taylor; Inge A Olesen; Grete Krag Jacobsen; Simon J McGowan; Susanne P Pfeifer; Gilean A T McVean; Ewa Rajpert-De Meyts; Andrew O M Wilkie
Journal:  Nat Genet       Date:  2009-10-25       Impact factor: 38.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.